CrossrefInfokarte
A Pilot Trial of N-803: Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
ONCOLOGY · 2026-10-28 · 40 (7)
DOI: 10.46883/2026.25921246 ↗Abstract
A pilot early phase 1 trial (NCT07261657) represents the first clinical effort to activate persisting transferred rare persisting cells by using IL-15 superagonist N-803.
EUVIMED